JP2004500431A - （ｒ，ｒ）−ホルモテロール及びロフレポニドを含む医薬組成物 - Google Patents

（ｒ，ｒ）−ホルモテロール及びロフレポニドを含む医薬組成物 Download PDF

Info

Publication number
JP2004500431A
JP2004500431A JP2001576038A JP2001576038A JP2004500431A JP 2004500431 A JP2004500431 A JP 2004500431A JP 2001576038 A JP2001576038 A JP 2001576038A JP 2001576038 A JP2001576038 A JP 2001576038A JP 2004500431 A JP2004500431 A JP 2004500431A
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
rofleponide
formoterol
acceptable salt
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001576038A
Other languages
English (en)
Japanese (ja)
Inventor
ガヴィン，ブライアン，チャールズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2004500431A publication Critical patent/JP2004500431A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2001576038A 2000-04-18 2001-04-11 （ｒ，ｒ）−ホルモテロール及びロフレポニドを含む医薬組成物 Pending JP2004500431A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009607.3A GB0009607D0 (en) 2000-04-18 2000-04-18 Medical compositions
PCT/GB2001/001629 WO2001078738A1 (fr) 2000-04-18 2001-04-11 Compositions medicales comprenant du (r,r)-formoterol et du rofleponide

Publications (1)

Publication Number Publication Date
JP2004500431A true JP2004500431A (ja) 2004-01-08

Family

ID=9890187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001576038A Pending JP2004500431A (ja) 2000-04-18 2001-04-11 （ｒ，ｒ）−ホルモテロール及びロフレポニドを含む医薬組成物

Country Status (5)

Country Link
EP (1) EP1274436A1 (fr)
JP (1) JP2004500431A (fr)
AU (1) AU4671701A (fr)
GB (1) GB0009607D0 (fr)
WO (1) WO2001078738A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004510732A (ja) * 2000-10-06 2004-04-08 オリオン　コーポレーション 喘息治療のための組合せ粒子
JP2015038118A (ja) * 2000-05-19 2015-02-26 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 新規組成物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
WO2004052374A1 (fr) 2002-12-12 2004-06-24 Altana Pharma Ag Medicament combine
AU2004246819A1 (en) * 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
WO2005025578A1 (fr) 2003-09-16 2005-03-24 Altana Pharma Ag Utilisation de ciclesonide dans le traitement de maladies respiratoires
CA2580019A1 (fr) * 2004-09-09 2006-03-16 Cipla Limited Composition pharmaceutique comportant un isomere d'un agent betamimetique et un agent anticholinergique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
CA2271004C (fr) * 1996-11-11 2007-05-01 Sepracor Inc. Procede de preparation d'isomeres de formoterol optiquement purs
CA2295076A1 (fr) * 1997-06-27 1999-01-07 Astra Aktiebolag Nouvelle combinaison de medicaments antiasthmatiques

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015038118A (ja) * 2000-05-19 2015-02-26 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 新規組成物
JP2004510732A (ja) * 2000-10-06 2004-04-08 オリオン　コーポレーション 喘息治療のための組合せ粒子
JP4768212B2 (ja) * 2000-10-06 2011-09-07 オリオン コーポレーション 喘息治療のための組合せ粒子

Also Published As

Publication number Publication date
AU4671701A (en) 2001-10-30
EP1274436A1 (fr) 2003-01-15
GB0009607D0 (en) 2000-06-07
WO2001078738A1 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
JP2004500429A (ja) チオトロピウム及びロフレポニドを含む医薬用の組み合わせ
JP2004500430A (ja) ホルモテロール及びブデソニドを含有する医薬用の組み合わせ
JP2004500433A (ja) チオトロピウムとブデソニドを含む組合せ医薬
JP2004538241A (ja) チオトロピウムとプロピオン酸フルチカゾンを含む組合せ医薬
WO2001078745A1 (fr) Produits composes a usage medical renfermant du formoterol et de la mometasone et du proprionate de fluticasone
JP2004500435A (ja) チオトロピウムとモメタゾンを含む組合せ医薬
CA2948553A1 (fr) Combinaisons de bromure de tiotropium, de formoterol et de budesonide pour le traitement de la bronchopneumopathie chronique obstructive
US20050042171A1 (en) Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
JP2004500434A (ja) サルメテロールとブデソニドを含む組合せ医薬
WO2001078744A1 (fr) Produits composes a usage medical renfermant du formoterol et de la mometasone
AU2002334126A1 (en) Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
JP2004500432A (ja) モメタゾンとサルメテロールを含む組合せ医薬
JP2004500431A (ja) （ｒ，ｒ）−ホルモテロール及びロフレポニドを含む医薬組成物
US20030096874A1 (en) Respiratory compositions
US20040019025A1 (en) Medical compositions comprising (r,r)-formoterol and rofleponide